Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 GeneticVariation disease BEFREE We identified heterozygous missense variants in ACTG2 in 7 of 17 families (~41%) diagnosed with CIPO and its associated conditions. 29781137 2018
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 GeneticVariation disease BEFREE Diagnosis of Chronic Intestinal Pseudo-obstruction and Megacystis by Sequencing the ACTG2 Gene. 28422808 2017
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 CausalMutation disease CLINVAR Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction. 26813947 2016
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 GeneticVariation disease BEFREE Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction. 26813947 2016
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 CausalMutation disease CLINVAR New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome). 25998219 2015
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 CausalMutation disease CLINVAR De novo ACTG2 mutations cause congenital distended bladder, microcolon, and intestinal hypoperistalsis. 24337657 2014
Entrez Id: 72
Gene Symbol: ACTG2
ACTG2
0.130 CausalMutation disease CLINVAR Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome. 24676022 2014
Entrez Id: 5885
Gene Symbol: RAD21
RAD21
0.020 GeneticVariation disease BEFREE A RAD21 loss-of-function mutation was found in cases of chronic intestinal pseudo-obstruction (CIPO) with associated enteric neuronal loss. 30069982 2018
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.020 Biomarker disease BEFREE We conducted a pilot study and assessed the efficacy and safety of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy in CIPO patients. 28631871 2017
Entrez Id: 5047
Gene Symbol: PAEP
PAEP
0.020 Biomarker disease BEFREE In this issue of the journal, Ohkubo et al showed promising data indicating that percutaneous endoscopic gastro-jejunostomy (PEG-J) can be proposed as a measure for intestinal decompression, thereby improving CIPO-associated abdominal symptoms, including pain. 29143474 2017
Entrez Id: 5885
Gene Symbol: RAD21
RAD21
0.020 GeneticVariation disease BEFREE We identified a homozygous mutation (p.622, encodes Ala>Thr) in RAD21 in patients from a consanguineous family with CIPO. 25575569 2015
Entrez Id: 4629
Gene Symbol: MYH11
MYH11
0.010 GeneticVariation disease BEFREE Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing. 31389005 2019
Entrez Id: 2670
Gene Symbol: GFAP
GFAP
0.010 Biomarker disease BEFREE GFAP increased in CIPO regardless the histopathological phenotype. 31144425 2019
Entrez Id: 100506658
Gene Symbol: OCLN
OCLN
0.010 Biomarker disease BEFREE Total occludin decreased in CIPO with AN and INF changes. 31144425 2019
Entrez Id: 1364
Gene Symbol: CLDN4
CLDN4
0.010 AlteredExpression disease BEFREE Claudin-4 was upregulated in CIPO with INF and DEG features. 31144425 2019
Entrez Id: 57217
Gene Symbol: TTC7A
TTC7A
0.010 Biomarker disease BEFREE Chronic Intestinal Pseudo-Obstruction and Lymphoproliferative Syndrome as a Novel Phenotype Associated With Tetratricopeptide Repeat Domain 7A Deficiency. 31787977 2019
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.010 Biomarker disease BEFREE We report the case of a 12-year-old boy with MD type 1 and CIPO, in which a pathologic assessment revealed an association with smooth muscle α-actin deficiency in the external muscular layer of the ileum, and with features of eosinophilic plexitis and eosinophilic muscle infiltration in the colon. 29749332 2018
Entrez Id: 1385
Gene Symbol: CREB1
CREB1
0.010 AlteredExpression disease BEFREE We found decreased levels of Gsa, FOXF1, CREB1, and phosphorylated CREB1 proteins in intestinal muscle layers of patients with chronic intestinal pseudo-obstruction, compared with tissues from controls. 28043906 2017
Entrez Id: 79827
Gene Symbol: CLMP
CLMP
0.010 GeneticVariation disease BEFREE We describe a newborn presenting CSBS intestinal malrotation and chronic intestinal pseudo-obstruction syndrome (CIPS), compound heterozygous for two previously unreported heterozygous mutations in Coxsackie and adenovirus receptor-like membrane protein (CLMP) gene, one in intron 1 (c.28+1G>C), the other on exon 4 (c502C>T, p.R168X). 27720179 2016
Entrez Id: 5979
Gene Symbol: RET
RET
0.010 GeneticVariation disease BEFREE Somehow, this RET R114H mutation proved to have a role in the etiology of both CIPO and HSCR and could contribute to a more diffuse imbalance of gut dysmotility. 27273837 2016
Entrez Id: 338
Gene Symbol: APOB
APOB
0.010 GeneticVariation disease BEFREE Some patients with CIPO carry mutations in RAD21 that disrupt the ability of its product to regulate genes such as RUNX1 and APOB. 25575569 2015
Entrez Id: 861
Gene Symbol: RUNX1
RUNX1
0.010 GeneticVariation disease BEFREE Some patients with CIPO carry mutations in RAD21 that disrupt the ability of its product to regulate genes such as RUNX1 and APOB. 25575569 2015
Entrez Id: 4567
Gene Symbol: TRNL1
TRNL1
0.010 GeneticVariation disease BEFREE To report on a family with five members who carry the A3243G mutation in mitochondrial tRNA for leucine 1 (MTTL1) and present with diabetes, chronic intestinal pseudo-obstruction (CIPO) and recurrent pancreatitis, and to screen for this mutation in a cohort of 36 unrelated patients with recurrent pancreatitis. 18955007 2008
Entrez Id: 3196
Gene Symbol: TLX2
TLX2
0.010 Biomarker disease BEFREE Evaluation of Hox11L1 in the fmc/fmc rat model of chronic intestinal pseudo-obstruction. 16291166 2005
Entrez Id: 6663
Gene Symbol: SOX10
SOX10
0.010 GeneticVariation disease BEFREE We found three SOX10 mutations, one EDNRB and one EDN3 mutations in patients presenting with the classical form of WS4, and two SOX10 mutations in patients displaying chronic intestinal pseudo-obstruction and WS features. 12189494 2002